• Categories
  • Archives

Viagra’s Patent Expires in Brazil. Market Is Flooded With Cheap Generic Pills

Viagra The day after Pfizer Inc’s patent for Viagra expired in Brazil, Carlos Sanchez flooded pharmacies with his generic erectile dysfunction pills. It was a day his army of lawyers, researchers and marketers had been preparing for more than three years, even winning a bid to move up the patent’s expiration date.

At a cost of 10 Reais (about US$ 4), Sanchez’s pills were five reais cheaper than Pfizer’s, which had cut its prices in half just weeks before the patent ended.

Sanchez’s copy of the little blue pill gave him an early foothold into the market for erectile dysfunction medicine in Brazil, where sales have quintupled in the last four years.

Consumers from an emerging middle class that pay for two-thirds of drug costs out of pocket tend to choose generics at the drug counter.

IMS Health (IMS) forecasts the industry will grow by 10% annually through 2019, as government subsidies for drug purchases and financing for innovation from Brazil’s state development bank offset economic growth that slowed to 2.2% in 2013, according to Geraldo Biasoto, economist at Universidade Estadual de Campinas.

While Brazil’s pharmaceutical industry isn’t known as a hotbed of innovation  –  Sanchez invests about half as much as Pfizer in research and development as a percentage of revenues – it hasn’t stopped drug copycats such as Sanchez from becoming billionaires.

Since taking over his family’s drug-store business at age 26, Sanchez has turned EMS Participacoes SA into a pharmaceutical company with revenue of two billion reais in 2013.

His net worth is valued at 2.9 billion, according to the Bloomberg Billionaires Index, including an art collection funded by years of dividends.

Maurizio Billi, the majority shareholder of the third-largest Brazilian drug producer, Eurofarma Laboratorios Ltda, has amassed a fortune worth more than 1.2 billion, while Ache Laboratorios Farmaceuticos SA, a Sao Paulo-based company that had sales of 1.9 billion Reais in 2013, has made billionaire fortunes for its three major shareholders, the Depieri, Baptista and Siaulys families.

Eurofarma and EMS are surpassed in scale by Laboratorio Neo Quimica, the pharmaceutical unit of consumer goods company Hypermarcas SA, which had revenue of 2.3 billion reais last year.

The two companies are the second- and third-biggest producers of sildenafil citrate pills in Brazil, trailed by Pfizer in sixth place, according to IMS Health.

EMS exports to more than 40 countries in Latin America, Europe, Africa and Asia.

Mercopress

Tags:

  • Show Comments (0)

Your email address will not be published. Required fields are marked *

comment *

  • name *

  • email *

  • website *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Ads

You May Also Like

Brazil Is Number 1 in Demanding Private Info and Censorship on Google Services

Brazil and United States topped the list of nations demanding private information about Google ...

Brazil, a Superpower in Cookie Consumption, Just Behind the US

Brazilian cookie exports totaled US$ 114 million last year, which represented growth of 24.5% ...

Brazil’s Development Banks to Lend US$ 22 bi, 50% More than in 2004

The Brazilian Development Bank (BNDES) made loans of approximately US$ 2.27 (in current figures) ...

Dirty Business

Staggering amounts of computers, batteries, televisions and other appliances, so-called technology trash, are filling ...

Exchange Students Leave Close to US$ 300 Million in Brazil Every Year

Brazil receives about 60,000 foreign students per year, according to information from a research ...

By Leaving Congress Cardozo Makes Himself Greater But Diminishes Brazil

José Eduardo Cardozo is one of this generation’s most respected, successful politicians. Serving his ...

The Works

They are into this quality certification process here big-time. Man, it is just sensational. ...

Brazilian Arab Community Offers Lula an Arab Dinner in Recognition

Next week, the Arab Brazilian Chamber of Commerce is going to pay homage to ...

Brazil’s Green Genetic Bank Soon to Be World’s Fourth Largest

Brazil is preparing to rise in the global ranking of leading holders of plant ...

Light Trading in Brazil While Varig Learns Bankruptcy Is the Best Medicine

Brazil’s stock market inched ahead, while Mexico receded. Investors are awaiting meaningful data from ...